Subsequently, glucose-stimulated insulin release from pancreatic isolated islets was assessed.<h4>Results</h4>HFD did not significantly change fasting plasma glucose, insulin and corticosterone levels, whereas increased plasma leptin (7.05 ± 0.33) and FFA (p < 0.01) levels and impaired glucose tolerance. The gene discussed is INS; the disease is Impaired glucose tolerance.